1. Home
  2. RGEN vs FN Comparison

RGEN vs FN Comparison

Compare RGEN & FN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • FN
  • Stock Information
  • Founded
  • RGEN 1981
  • FN 1999
  • Country
  • RGEN United States
  • FN Cayman Islands
  • Employees
  • RGEN N/A
  • FN N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • FN Telecommunications Equipment
  • Sector
  • RGEN Health Care
  • FN Utilities
  • Exchange
  • RGEN Nasdaq
  • FN Nasdaq
  • Market Cap
  • RGEN 7.6B
  • FN 8.3B
  • IPO Year
  • RGEN N/A
  • FN 2010
  • Fundamental
  • Price
  • RGEN $156.55
  • FN $227.44
  • Analyst Decision
  • RGEN Buy
  • FN Buy
  • Analyst Count
  • RGEN 12
  • FN 8
  • Target Price
  • RGEN $187.44
  • FN $255.63
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • FN 420.8K
  • Earning Date
  • RGEN 02-19-2025
  • FN 02-03-2025
  • Dividend Yield
  • RGEN N/A
  • FN N/A
  • EPS Growth
  • RGEN N/A
  • FN 25.19
  • EPS
  • RGEN N/A
  • FN 8.45
  • Revenue
  • RGEN $633,513,000.00
  • FN $3,001,718,000.00
  • Revenue This Year
  • RGEN $2.28
  • FN $18.42
  • Revenue Next Year
  • RGEN $9.88
  • FN $13.18
  • P/E Ratio
  • RGEN N/A
  • FN $26.91
  • Revenue Growth
  • RGEN N/A
  • FN 12.20
  • 52 Week Low
  • RGEN $113.50
  • FN $159.69
  • 52 Week High
  • RGEN $211.13
  • FN $278.38
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • FN 48.43
  • Support Level
  • RGEN $149.15
  • FN $216.78
  • Resistance Level
  • RGEN $160.64
  • FN $240.51
  • Average True Range (ATR)
  • RGEN 5.96
  • FN 7.06
  • MACD
  • RGEN 0.91
  • FN 0.86
  • Stochastic Oscillator
  • RGEN 79.57
  • FN 53.65

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About FN Fabrinet

Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

Share on Social Networks: